The AMP-activated protein kinase (AMPK) is a key regulator of energy balance expressed Hardie et al AMPK: multiple inputs and outputs 3 AMPKsubunit structure and regulation 32 The AMP-activated protein kinase (AMPK) is a key sensor of cellular energy status present in 33 essentially all eukaryotic cells, where it occurs as heterotrimers comprising catalytic  subunits and 34 regulatory  and  subunits [1] [2][3]. Genes encoding at least one of these subunits are found in the 35 genomes of essentially all eukaryotes, while mammals have genes encoding multiple isoforms (1, 36 2; 1, 2; 1, 2, 3). AMPK heterotrimers are normally only significantly active after 37 phosphorylation of a conserved threonine residue within the activation loop of the  subunit kinase 38 domain (Thr172 in rat 2 [4]; the numbering may differ in other species). Mammalian AMPK is 39 activated through binding of 5'-AMP by three complementary effects (Fig. 1): i. promotion of 40 Thr172 phosphorylation by upstream kinases; ii. inhibition of Thr172 dephosphorylation by protein 41 phosphatases; and iii. allosteric activation. Although allosteric activation is only triggered by 42 binding of AMP, effect #1 (promotion of Thr172 phosphorylation [5]) and #2 (inhibition of Thr172 43 dephosphorylation [6, 7]) can be mimicked by ADP. Since ATP antagonizes these effects, AMPK 44 acts as a sensor of cellular AMP:ATP and ADP:ATP ratios, both of which increase during cellular 45 energy stress (although the changes in AMP:ATP are always larger due to the adenylate kinase 46 reaction [7]). AMPK can sense small changes in AMP even in the presence of concentrations of 47
ubiquitously in eukaryotic cells. Here, we review the canonical adenine nucleotide-dependent 23 mechanism that activates AMPK when cellular energy status is compromised, as well as other, non-24 canonical activation mechanisms. Once activated, AMPK acts to restore energy homeostasis by 25 promoting catabolic pathways, resulting in ATP generation, and inhibiting anabolic pathways that 26 consume ATP. We also review the various hypothesis-driven and unbiased approaches that have 27 been used to identify AMPK substrates, which have revealed substrates involved in both metabolic 28 and non-metabolic processes. We particularly focus on methods for identifying the AMPK target 29 recognition motif, and how it can be used to predict new substrates. 30 31 ATP at site 3 would not allow the same interaction with -RIM2. Supporting this, the interaction 90 between an -AID:linker fragment and a construct containing the  subunit was shown by 91 luminescence energy transfer to be enhanced by AMP binding, but decreased by ATP binding [8] . 92
Recent experiments with a novel AMPK activator suggest that the ability of AMP analogs to 93 protect against Thr172 dephosphorylation (effect #2) is also due to binding at site 3. C13 (see Fig.  94 4A) is a phosphonate diester that is taken up into cells and converted by cellular esterases to C2, a 95 potent AMP analog [20] . In cell-free assays, C2 promoted effects #2 (protection against Thr172 96 dephosphorylation) and #3 (allosteric activation) using 1-containing complexes, but in 2-97 containing complexes, it was only a partial allosteric agonist compared to AMP, and failed to 98 protect against Thr172 dephosphorylation. However, the full effects could be transferred to 2- What is the exact mechanism for effect #2 (protection against Thr172 dephosphorylation)? 105 Current structures of the heterotrimer, which are in active conformations with AMP bound in site 3, 106
can be divided into two major regions termed the "catalytic module" (upper left in Fig. 2) and 107 "nucleotide-binding" module (lower right in Fig. 2 ), with Thr172 located in the cleft between them. 108
The -linker can be regarded as a flexible connector linking these two modules, and its release from 109 the  subunit when ATP replaces AMP at site 3 may allow the catalytic and nucleotide-binding 110 modules to move apart, increasing the accessibility of Thr172 to phosphatases, thus inducing 111 dephosphorylation [6]. This movement would also allow the -AID to move back into its inhibitory 112 position behind the -KD, thus reversing allosteric activation. In support of this model, 113 measurements of small angle X-ray scattering [22] , and luminescence energy transfer [8] both 114 suggest that heterotrimers adopt less compact conformations when ATP, rather than AMP, is 115
bound. 116
The explanation for effect #1 (promotion of Thr172 phosphorylation by LKB1) remains 117 unknown, although an intriguing recent proposal is that AMP binding causes AMPK to co-localize 118 with LKB1 due to their mutual interactions with the scaffold protein axin, which in turn binds to LAMTOR1 at the surface of the lysosome [23, 24] . However, effect #1 can also be observed on 120 reconstitution of highly purified LKB1 and AMPK [7], suggesting that it does not strictly require 121 these additional components. 122
Non-canonical inputs -activation by ligands that bind between the  and  subunits 123
Many screens of candidate molecules, as well as unbiased screens, have been conducted in the hunt 124 for AMPK activators that might have therapeutic potential. A small selection of known activators is carbohydrate-binding module (-CBM), which is related to non-catalytic domains found in 131 enzymes that metabolize glycogen or starch, and has been shown to cause binding of AMPK to 132 glycogen particles within cells [28, 29] . In the structure shown in Fig. 2 , the synthetic 133 oligosaccharide -cyclodextrin was bound at the presumed glycogen-binding site. In other recent 134 structural analyses [12, 13], A-769662 or another activator, 991 (also known as ex229 [30]), was 135 bound at the opposite surface of the -CBM, in the cleft between it and the -KD N-lobe; this cleft 136 is labeled in Fig. 2 although unoccupied. A-769662 and 991 are synthetic molecules, but the natural 137 plant product and AMPK activator, salicylate, was suggested to bind at the same site [31]; this was 138 recently confirmed by a crystal structure containing bound 5-iodosalicylate [13] . Salicylate (in the 139 form of willow bark extracts) has been used as a medicine since ancient times, with acetyl salicylic 140 acid (aspirin) being a synthetic derivative that is rapidly broken down to salicylate in vivo. 141
However, this leaves open the question as to whether there is a naturally occurring metabolite in 142 mammals that regulates AMPK by binding this site. Although such a metabolite has not yet been 143 found, the site has been referred to as the allosteric drug and metabolite (ADaM) binding pocket 144
[32]. 145
Non-canonical inputsactivation by the Ca 2+ /CaMKK pathway 146
Hormones that increase intracellular Ca 2+ activate AMPK via phosphorylation of Thr172 by the 147 calmodulin-dependent protein kinase CaMKK ( Fig. 1 ) [33] [34] [35] . This represents an alternate, Ca 2+ -dependent pathway for AMPK activation that is independent of changes in adenine nucleotides and 149 is therefore considered to be non-canonical. However, because AMP binding inhibits Thr172 150 dephosphorylation, the two pathways can act synergistically [36] . 151
Indirect mechanisms for AMPK activation 152
Most other activators ( Fig. 4C ) activate AMPK indirectly by inhibiting ATP synthesis, thus 153 increasing intracellular AMP:ATP and ADP:ATP ratios [37]. These include the glycolytic inhibitor 154 2-deoxyglucose, the anti-diabetic drugs metformin and phenformin, and many natural plant 155 products that are either used in traditional medicines or are being tested for health-promoting 156
activities (e.g. berberine [38] , arctigenin [39], and resveratrol [40]). Another interesting activation 157 mechanism is displayed by the tetrahydrofolate analogs pemetrexed and methotrexate, used for 158 treatment of cancer or inflammatory disorders such as rheumatoid arthritis. These analogs inhibit 159 tetrahydrofolate-utilizing enzymes, including the transformylase that catalyzes the first step in the 160 metabolism of ZMP, the phosphorylated form of AICAR, to purine nucleotides (although inhibition 161 by methotrexate is most likely secondary to inhibition of dihydrofolate reductase [41]). They 162 therefore cause accumulation of cellular ZMP, which binds to the  subunit and activates AMPK 163 
Outputs: identification of downstream targets 165
Once AMPK is activated, it acts to restore energy homeostasis by activating catabolic pathways that 166 generate ATP and inhibiting anabolic pathways that consume ATP. However, since the great 167 majority of cellular processes consume energy and most are coupled to ATP hydrolysis, there is no 168 reason why processes switched off by AMPK should be restricted to metabolic roles. There has 169 therefore been a need to understand how AMPK recognizes its target phosphorylation sites, and to 170 develop methods to screen for, and even predict, novel downstream targets. This will form the 171 central theme of the remainder of this review, and some of the methods used are illustrated in Fig.  172 
173

Initial hypothesis-driven approaches to determine the AMPK recognition motif 174
Sequencing of the first few sites phosphorylated by AMPK led to the identification of conserved 175 residues close to the phosphoacceptor site (P), including basic residues at P-3 and/or P-4 and around Ser79 on rat acetyl-CoA carboxylase-1 (ACC1) and was the first peptide substrate for 179 AMPK [44]. This study also showed that AMPK would phosphorylate threonine, although serine 180 was preferred (this preference for serine is a feature of serine/threonine kinases in general). A 181 follow-up study utilized a specially designed peptide sequence (AMARAASAAALA) where all 182 residues other than the serine and the critical positions at P-5, P-3, and P+4 were alanine. This study 183 showed that the mammalian, budding yeast, and higher plant orthologs of AMPK had very similar 184 specificities, and that the position as well as the chemical nature of the P-5, P-3 and P+4 residues 185 was crucial, although the basic residue could be at P-4 or P-3 [45] . Another approach used a 186 bacterially expressed peptide containing 34 residues around the Ser79 site on rat ACC1 as the although not all known AMPK substrates contain this. This study also suggested that the sequence 192 N-terminal to P-5 in ACC1, in which conserved hydrophobic residues occur every 3-4 residues (at 193 P-5, P-9, P-13 and P-16), form an amphipathic -helix that fits into a hydrophobic groove within 194 the C lobe of the -KD. Interestingly, a partial structure of another AMPK target, HMG-CoA 195 reductase [47], revealed that residues from Gly860 to Arg871 (corresponding to P-12 to P-1 with 196 respect to the phosphorylation site, Ser872) do form such an -helix. However, this amphipathic 197 helix cannot be essential for target recognition, because it is not present in the peptide substrates, or 198 in the liver or muscle isoforms of glycogen synthase, two well-validated targets for AMPK where 199 the P-6 residues actually form the N-termini of the mature proteins. These -helices should 200 therefore be regarded as docking sites that enhance the affinity of the kinase-substrate interaction, 201 rather than as essential determinants for substrate recognition. 202
Unbiased approaches to determine the recognition motif 203
The studies described in the previous section were built on hypotheses about substrate recognition 204 derived from sequences of a relatively small number of known targets. More recently, unbiased screens to identify the preferred AMPK recognition motif have been developed. The first was a 206 peptide library approach using spatially arrayed sets of peptide mixtures [48], a method originally 207 developed for studies of other kinases [49] . Each mixture contained a fixed amino acid at a given 208 position relative to a central fixed serine/threonine phosphoacceptor, with mixtures at all other 209 positions ( Fig. 5B ). From the relative amount of phosphate incorporated into each mixture, a 210 measure of selectivity for and against individual amino acids at each position was obtained. 211
Gratifyingly, the results yielded a recognition motif remarkably similar to the earlier approaches, 212 with hydrophobic side chains being preferred at P-5 (especially M or L) and P+4 (I, L, M or F), and 213 basic side chains (R>K) at the P-4 or P-3 position; a preference for polar side chains at P+3 was 214 also noted [48] . One drawback of this approach is that it is not feasible to study the effects of amino 215 acids more than about five residues away from the phosphoacceptor, because the peptide mixtures 216 become too degenerate. . This initial approach did not identify the actual phosphorylation sites, but the known 225 AMPK recognition motif was used to predict the phosphorylation sites on four (PPP1R12C, 226 BAIAP2, CDC27 and PAK2), which were subsequently independently validated [50] . 227
Since existing AMPK recognition motifs were used in this approach to identify the likely sites, 228 sites that did not adhere to these motifs would have been missed. Another drawback was that it 229 might identify as false positives proteins that co-precipitated with the thiophosphorylated substrates. 230
A recent refinement of this method allows concurrent identification of both the substrate and its 231 thiophosphorylation site(s): the thiophosphorylated proteins are digested with trypsin and the 232 modified peptides isolated via a peptide capture approach, allowing the sites to be directly identified 233 by tandem mass spectrometry [53] . When applied to AMPK (Fig. 5C) [54], the 32 phosphorylation 234 sites (27 of them novel) most frequently identified across replicate screens showed striking resemblance to the established AMPK phosphorylation motif [43, 45, 46, 48] . Hydrophobic 236 residues (L, M, I) were observed at P-5, basic residues (R>K), usually at P-3 but also occasionally 237 at P-4 or P-2, neutral polar residues (S, N, T, Q) at P-2, polar and/or charged residues (S, D, N) at 238 P+3, and hydrophobic residues (usually L) at P+4 [54] . As suggested by an earlier approach [46], a 239 subset of sites contained basic residues at P-6, although they were not present at all sites. Some of 240 the novel sites [54], as well as many established AMPK target sites (see supplementary Table 1 for 241 an updated list of 64 well-validated AMPK target sites, and Fig. 6 ), contain proline at P+2, which is 242 not selected in screens utilizing cell-free assays [48] . This is most likely due to the functional 243 overlap between AMPK phosphorylation motifs and 14-3-3 binding sites, with the latter usually 244 having a phosphoserine with R at P-3, S at P-2, and P at P+2 [55] . No strong distal motif outside of 245 P-5 to P+4 emerged from analysis of the phosphorylation sites identified in this study [54] or of 64 246 well-validated AMPK sites (supplementary Table 1 ), suggesting that the primary recognition motif 247 is contained within this window. It should also be noted that the target sequences listed in 248
supplementary Table 1 
Prediction of novel targets using the AMPK recognition motif
254 AMPK now has a recognition motif ( Fig. 6 ) that is among the best defined of any protein kinase, 255 making it potentially useful for predicting novel targets. It is important to note, however, that there 256 are likely to be many sites that conform to this motif that are not targets for AMPK, either because 257 they are not accessible to the kinase due to some aspect of structure or protein:protein interaction, or 258 because of their subcellular location. Since important phosphorylation sites are likely to be 259 conserved, several groups have searched protein databases to find motifs matching earlier versions 260 of the recognition motif, and then filtered their results by evolutionary conservation. This led to the 261 identification of phosphorylation sites with important regulatory functions on RAPTOR [48], ULK1 262
[59], Class IIA histone deacetylases [60], and AMOTL1, the latter involved in Hippo signaling 263
[61]. Since AMPK phosphorylation often triggers 14-3-3 binding, the identification of some of manner. Recently, a similar analysis was conducted, searching for motifs in the proteome 266 containing basic residues at P-6 and P-4 and hydrophobic residues at P-5 and P+4, and several sites 267 predicted were validated as AMPK targets in cell-free assays [62] . In a parallel approach, an 268 antibody recognizing the core recognition motif (LxRxxpS/pT) was used to immunoprecipitate 269 proteins following AMPK activation in hepatocytes, which were then identified by mass 270 spectrometry. The majority of the proteins identified did contain that motif, and several of these 271
were validated as AMPK targets [63] . Finally, it might be worth noting that AMPK does seem to tolerate a little more flexibility in its 288 recognition motif than many other protein kinases. Thus, it will accept histidine rather than arginine 289 or lysine as the basic residue at P-3 or P-4, which many other "Basophilic" kinases do not. 290
Moreover, it appears to accept a little slippage in the exact position of the hydrophobic residue at P-291 5. Thus, in NOS1, NOS3, PAK2 and PFKFB2 the hydrophobic residue is at P-4 rather than P-5, 292 although in all these cases it is followed by an arginine at P-3 (Supplementary Table 1 ). outlined in the Outstanding Questions. AMPK is now known to be activated through a variety of 296 upstream inputs, including the canonical mechanism involving sensing of adenine nucleotide ratios, 297
and non-canonical mechanisms such as those used by compounds that bind at the ADaM site, and 298 the Ca 2+ -dependent pathway involving CaMKK. 299
The number of outputs, i.e. identified downstream targets, is also expanding rapidly. The 300 availability of phosphorylation site prediction tools should greatly assist in elucidation of the 301 complete network of downstream targets. However, the current site prediction tools do have some 302 limitations. AMPK-1 and -2 lie in the same branch of the kinome as up to twelve AMPK-related 303 kinases, and some of the latter, notably the MARKs [69], have similar recognition motifs. Thus, 304
using the AMPK recognition motif to predict sites may also yield targets for AMPK-related kinases. 305
Covalent modifications within the proximity of the target site (such as oxidation of methionine 306
when this is the hydrophobic residue at P-5 [70]) might also affect recognition. In addition, 307 sequences and/or higher order structures outside of the P-5 to P+4 window, such as the amphipathic 308 helix from P-15 to P-5 upstream of Ser79 on ACC1, can enhance the recognition of specific sites. 309
Because these are not essential, the increased power they could bring to site prediction is currently 310 lost. One future direction might be to investigate whether multiple subsets of distal recognition 311 motifs exist, which might contain elements that increase predictive power. Further exploration of 312 the network in different contexts, for example when activated by different inputs, will be a key step Bass Stanford Graduate Fellowship (BES), NIH T32 CA09302 (BES). We also thank all of those 320 researchers who have contributed to the development of the AMPK story whose work we could not 321 cite due to constraints on the length of the article. 
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